We are live on
!
Find out more
DY
Dowling & Yahnke Portfolio holdings
AUM
$2.15B
Turnover
6.98%
1-Year Est. Return
10.82%
This Fund
S&P 500
This Quarter
Est. Return
-4.54%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$2.15B
AUM Growth
+$21.9M
(+1%)
Cap. Flow
+$140M
Cap. Flow
% of AUM
6.52%
Top 10 Holdings %
Top 10 Hldgs %
29.72%
Holding
387
New
13
Increased
178
Reduced
139
Closed
14
Avg Time Held
5.5
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional International Core Equity Market ETF
DFAI
|
+$30.3M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$24.2M |
| 3 |
Vanguard Total International Stock ETF
VXUS
|
+$23.3M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$13.8M |
| 5 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$10.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$16.8M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$4.06M |
| 3 |
Northrop Grumman
NOC
|
+$2.81M |
| 4 |
Leidos
LDOS
|
+$2.15M |
| 5 |
Saic
SAIC
|
+$1.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.91% |
| 2 | Technology | 10.65% |
| 3 | Healthcare | 9.36% |
| 4 | Financials | 6.57% |
| 5 | Consumer Staples | 5.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
SLB Ltd
SLB
$71.8B
| $708K | 0.03% |
19,716
+256
| +1% | +$9.28K |
2013 Q2
37 quarters
|
|
252
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.2B
| $706K | 0.03% |
9,914
-2,220
| -18% | -$174K |
2017 Q2
21 quarters
|
|
253
Fate Therapeutics
FATE
$231M
| $687K | 0.03% |
30,640
| – | – |
2021 Q2
5 quarters
|
|
254
iShares Russell 1000 ETF
IWB
$49.2B
| $653K | 0.03% |
3,309
-37
| -1% | -$8.11K |
2014 Q4
31 quarters
|
|
255
Prudential Financial
PRU
$40.1B
| $649K | 0.03% |
7,562
-66
| -0.9% | -$6.35K |
2013 Q2
37 quarters
|
|
256
Hershey
HSY
$33.9B
| $647K | 0.03% |
2,937
+35
| +1% | +$7.84K |
2020 Q4
7 quarters
|
|
257
CACI
CACI
$13.5B
| $640K | 0.03% |
2,450
| – | – |
2017 Q1
22 quarters
|
|
258
iShares Select Dividend ETF
DVY
$23B
| $629K | 0.03% |
5,866
+500
| +9% | +$59.9K |
2014 Q1
34 quarters
|
|
259
Invesco S&P 500 Equal Weight ETF
RSP
$98.2B
| $598K | 0.03% |
4,698
+378
| +9% | +$53.3K |
2017 Q3
20 quarters
|
|
260
Yum China
YUMC
$15.1B
| $597K | 0.03% |
12,612
-205
| -2% | -$9.85K |
2016 Q4
23 quarters
|
|
261
State Street SPDR Dow Jones International Real Estate ETF
RWX
$244M
| $591K | 0.03% |
24,504
-330
| -1% | -$9.22K |
2017 Q4
19 quarters
|
|
262
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.2B
| $589K | 0.03% |
2,051
-1
| -0% | -$318 |
2013 Q2
37 quarters
|
|
263
iShares MSCI ACWI ETF
ACWI
$32.9B
| $587K | 0.03% |
7,538
| – | – |
2016 Q2
25 quarters
|
|
264
NextEra Energy
NEE
$165B
| $580K | 0.03% |
7,395
-1,990
| -21% | -$169K |
2015 Q4
27 quarters
|
|
265
Avantis US Equity ETF
AVUS
$14.7B
| $564K | 0.03% |
+9,047
| New | +$621K |
2022 Q3
0 quarters
|
|
266
SPDR Gold Trust
GLD
$142B
| $562K | 0.03% |
3,631
+889
| +32% | +$143K |
2020 Q1
10 quarters
|
|
267
McKesson
MCK
$116B
| $555K | 0.03% |
1,632
-113
| -6% | -$39.2K |
2019 Q1
14 quarters
|
|
268
iShares Russell 2500 ETF
SMMD
$4.01B
| $554K | 0.03% |
11,131
+91
| +0.8% | +$5.02K |
2022 Q2
1 quarter
|
|
269
State Street Health Care Select Sector SPDR ETF
XLV
$45.9B
| $553K | 0.03% |
4,564
+317
| +7% | +$40.8K |
2017 Q2
21 quarters
|
|
|
MRTX
270
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $552K | 0.03% |
+7,900
| New | +$585K |
2022 Q3
0 quarters
|
|
271
Eaton
ETN
$156B
| $547K | 0.03% |
4,103
+461
| +13% | +$64.5K |
2021 Q2
5 quarters
|
|
272
iShares US Energy ETF
IYE
$1.74B
| $531K | 0.02% |
13,510
| – | – |
2019 Q4
11 quarters
|
|
273
iShares TIPS Bond ETF
TIP
$14.4B
| $530K | 0.02% |
5,052
-1,184
| -19% | -$134K |
2017 Q4
19 quarters
|
|
274
iShares MSCI USA Momentum Factor ETF
MTUM
$19.1B
| $522K | 0.02% |
3,976
| – | – |
2020 Q2
9 quarters
|
|
275
ResMed
RMD
$34.1B
| $515K | 0.02% |
2,358
+18
| +0.8% | +$4.1K |
2017 Q4
19 quarters
|
|
Similar funds
AC
APA
IC
SCA
ACM
W
Dowling & Yahnke's Q3 2022 Portfolio in Review
As of Q3 2022, Dowling & Yahnke held 387 positions worth $2.15B, up 1% from $2.13B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Dowling & Yahnke deployed $140M of net new capital in Q3 2022, opening 13 new positions and adding to 178 existing holdings. Its largest new stake was U.S. High Relative Profitability Portfolio ETF Class Shares: 161,010 shares worth $3.44M.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 49% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $16.8M trimmed.
- Dowling & Yahnke's largest Q3 2022 buy was U.S. High Relative Profitability Portfolio ETF Class Shares: 161,010 shares worth $3.44M.
- Dowling & Yahnke added most to Dimensional International Core Equity Market ETF in Q3 2022, an estimated $30.3M increase.
- Dowling & Yahnke's biggest Q3 2022 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $16.8M.
- Dowling & Yahnke fully exited Saic in Q3 2022, selling an estimated $1.57M.
- Dowling & Yahnke's ten largest holdings make up 30% of its $2.15B portfolio in Q3 2022.
- Dowling & Yahnke opened 13 new positions and closed 14 in Q3 2022.
- Dowling & Yahnke's portfolio value rose 1% quarter-over-quarter to $2.15B.
Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.